Active Substance

izokibep

Therapeutic area

Immunology-Rheumatology-Transplantation

Decision number

P/0268/2023

PIP number

EMEA-003325-PIP01-22

Pharmaceutical form(s)

Solution for injection

Condition(s) / indication(s)

Treatment of chronic idiopathic arthritis (including rheumatoid arthritis, ankylosing spondylarthritis, psoriatic arthritis, and juvenile idiopathic arthritis)

Route(s) of administration

Subcutaneous use

Contact for public enquiries

Decision type

P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision date

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.